Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReact Group Regulatory News (REAT)

Share Price Information for React Group (REAT)

Share Price is delayed by 15 minutes
Get Live Data
45.50    0.00 (0.00%)
Bid:
44.00
Ask:
47.00
Spread: 3.00 (6.818%)
Market Cap: £10.75m
REAT Live PriceLast checked at - London Stock Exchange

Intraday React Group Share Chart

New Convertible Loan Agreement

27 Nov 2013 07:00

RNS Number : 0130U
Verdes Management PLC
27 November 2013
 



Embargoed for 700am : 27 November 2013

Verdes Management PLC

New Convertible Loan Agreement

 

 

27 November 2013



 

Verdes Management PLC

 

New Convertible Loan Agreement

 

("Verdes" or the "Company")

 

 

Further to the announcement of 26 November 2013, the Board of Verdes Management PLC (AIM: VMP) is pleased to confirm it has today signed another new convertible loan agreement to provide up to £25,000 of loan capital to the Company to allow it to develop its new strategy.

 

The convertible loan is being provided by Mr Peter Wildey (the "Wildey Convertible Loan"). Mr Wildey is referred to herein as "the Lender".

 

Terms of the Wildey Convertible Loan

 

The Wildey Convertible Loan has the following principal terms:

 

Amount: £25,000.

 

Advance of Funds:

 

The £25,000 under the Wildey Convertible Loan has been received.

 

Term and Repayment:The Wildey Convertible Loan is repayable (to the extent conversion has not occurred) 30 months from the date of the drawdown of the Wildey Convertible Loan ly. The outstanding amount of the Wildey Convertible Loan which has not been converted into ordinary shares in the Company, is repayable in full 30 months after the date of draw down (subject to earlier demand by the Lender in the event of insolvency or a change of control affecting Verdes).

 

Security: the Wildey Convertible Loan is unsecured.

 

Conversion: The amount outstanding of the Wildey Convertible Loan is convertible by notice from the Lender at any time into ordinary shares of 0.1p each in the Company ("Ordinary Shares") at a conversion price ("Conversion Price") of 0.055p per Ordinary Share (or an equivalent price following the capital reorganisation ("Capital Reorganisation") required to allow the issue of new shares). This is the same price as the price at which the Newick Convertible Loan entered into on 3 October 2013 is convertible.

 

However, in the event that the prevailing share price is less than 0.055p at the time of conversion, the Conversion Price will be reduced to be the average of the closing mid-market share price for the 10 business days preceding the date of conversion, but the Conversion Price will not be lower than 0.05p per new ordinary share.

 

The Wildey Convertible Loan would convert into 45,454,545 new Ordinary Shares representing 6.89% of the Company's current issued share capital.

 

If the Conversion Price is reduced to the minimum price of 0.05p, the number of shares issued would amount to 50,000,000 constituting approximately 7.58% of the current issued Ordinary Share capital - assuming no other new Ordinary Shares are issued in the intervening period (approximately 7.63% of the voting Ordinary Share capital when the 64,000,000 forfeited Ordinary Shares (as set out in the RNS announcement of 5 March 2013) are excluded).

 

Shareholders' approvals: The Company is required to call a General Meeting of the Company to put resolutions to shareholders to effect the capital reorganisation necessary to allow conversion of the Wildey Convertible Loan into Ordinary Shares at the Conversion Price.

In the event that the resolutions referred to above are not passed at General Meeting, the Wildey Convertible Loan (and all outstanding interest) will become repayable on 15 days' notice by the Lender.

Interest rate:0%. However, this rate will increase to 5% from the date of draw down in the event that the approval of shareholders to conversion of the Wildey Convertible Loan (see above) is not obtained the first time it is sought.

 

Capital Reorganisation: As previously announced (on 4 October 2013) the Company will take the opportunity at a general meeting to be convened shortly to propose resolutions to enable the Company to issue Ordinary Shares at the Conversion Price on conversion of the existing convertible loans (the Newick Convertible Loan and the convertible loan issued to Westminster Asset Management Limited ("Westminster Convertible Loan") as announced via RNS on 5 March 2013). Approval of these resolutions will also allow the conversion of the Wildey Convertible Loan (and the RAB Convertible Loan announced on 26 November 2013). The capital reorganisation will involve a reduction in the nominal value of the Ordinary Shares to allow conversion to take place and the cancellation of the outstanding deferred shares in the Company.

 

Use of Funds: The Wildey Convertible Loan will enable the introduction of further working capital to Verdes in order to facilitate the development of a new business model which is being prepared with a view to providing increased shareholder value.

 

For further information please contact:

Verdes Management PLC

Daan van den Noort - Chairman 00 31 6 10 89 65 81

Jan Geertman - Consultant to the Board 07825 501627

 

SPARK Advisory Partners Limited (Nominated Adviser)

Neil Baldwin 0113 370 8974

Mark Brady 0113 370 8971

 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRMMMZMRVZGFZM
Date   Source Headline
17th Jun 202611:56 amRNSDirector/PDMR Shareholding
19th May 202611:23 amRNSInvestor Presentation via Investor Meet Company
19th May 20267:00 amRNSInterim Results and Investor Presentation
13th May 20265:17 pmRNSDirector/PDMR Shareholding
15th Apr 202610:25 amRNSDirector/PDMR Shareholding
31st Mar 20267:28 amRNSAGM Statement
27th Mar 202610:16 amRNSNotice of AGM
13th Feb 20264:22 pmRNSHolding(s) in Company
13th Feb 20264:13 pmRNSHolding(s) in Company
13th Feb 20263:03 pmRNSDirector/PDMR Shareholding
13th Feb 20261:11 pmRNSDirector/PDMR Shareholding
12th Feb 20265:18 pmRNSHolding(s) in Company
12th Feb 202611:35 amRNSHolding(s) in Company
11th Feb 20264:18 pmRNSHolding(s) in Company
10th Feb 20264:33 pmRNSPDMR Dealings
5th Feb 20267:00 amRNSFinal Results
2nd Feb 20267:00 amRNSNotice of Results
19th Jan 20263:37 pmRNSHolding(s) in Company
13th Jan 20262:56 pmRNSDirector/PDMR Shareholding
9th Jan 20263:03 pmRNSHolding(s) in Company
2nd Jan 202611:15 amRNSDirector/PDMR Shareholding
15th Dec 20254:28 pmRNSDirector/PDMR Shareholding
14th Nov 20253:43 pmRNSHolding(s) in Company
28th Oct 20257:00 amRNSTrading Update
16th Oct 20255:18 pmRNSDirector/PDMR Shareholding
16th Sep 20259:13 amRNSDirector/PDMR Shareholding
14th Aug 202511:31 amRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSContract Wins
16th Jul 20252:38 pmRNSShare Incentive Plan
15th Jul 20251:53 pmRNSHolding(s) in Company
27th May 20257:00 amRNSInterim Results & Trading Update
19th May 20258:27 amRNSHolding(s) in Company
29th Apr 202512:30 pmRNSHolding(s) in Company
25th Apr 20252:35 pmRNSHolding(s) in Company
27th Mar 20251:15 pmRNSResult of AGM
27th Mar 20257:00 amRNSAGM Statement
19th Mar 20253:01 pmRNSDirector/PDMR Shareholding
19th Mar 20251:15 pmRNSHolding(s) in Company
6th Mar 202512:09 pmRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSNotice of AGM
12th Feb 20253:34 pmRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNS-RContract Win
30th Jan 20251:59 pmRNSHolding(s) in Company
29th Jan 202511:11 amRNSInvestor Presentation
29th Jan 20257:00 amRNSFinal Results
28th Jan 20256:07 pmRNSHolding(s) in Company
21st Jan 20252:00 pmRNSHolding(s) in Company
8th Nov 20245:12 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSExercise of Options & Total Voting Rights
30th Oct 20243:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.